Homology Medicines Inc
Homology Medicines Inc logo
FIXX

Homology Medicines Inc (FIXX)

$1.442.04%

Market is closed
– opens on 8 PM, 07 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$1.4
Day's Range
$1.54
$1.3
52-Week Range
$5.15
1 month return0.0%
3 month return32.71%
1 year return70.67%
5 year return92.28%

Company Information

Homology Medicines, Inc. is a clinical-stage genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Homology's proprietary platform is designed to utilize its human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a broad range of genetic disorders. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its family of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
OrganizationHomology Medicines Inc
Employees224
CEODr. Albert Seymour Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 10 analysts ratings

Buy
90%
Buy
10%
Hold
0%
Sell

Based on 10 Wall street analysts offering stock ratings for Homology Medicines Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 465.28%

Current

$1.44

Target

$8.14

Recommendation Trend

Based on 10 analyst

Current1M Ago3M Ago
Buy
9
11
11
Hold
1
5
5
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
84.5M
Book Value
$3.64
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.05
Wall Street Target Price
8.14

Valuation

Trailing PE0.0
Forward PE22.27
Price/Book (mrq)
0.42
Enterprise Value
-84451279
Enterprise Value/Revenue
0.41
Enterprise Value/Ebitda
0.65

Technicals

Beta
-0.18
50 Day MA
1.53
200 Day MA
2.13

Institutional Holdings

Temasek Holdings Ltd.

9.83%

5AM Venture Management, LLC

7.89%

Vanguard Group Inc

3.56%

BlackRock Inc

2.85%

Bellevue Group AG

2.82%

Citadel Advisors Llc

1.83%

Discover more

Frequently Asked Questions

What is Homology Medicines Inc share price today?

Can Indians buy Homology Medicines Inc shares?

How can I buy Homology Medicines Inc shares from India?

Can Fractional shares of Homology Medicines Inc be purchased?

What are the documents required to start investing in Homology Medicines Inc stocks?

What are today’s High and Low prices of Homology Medicines Inc?

What are today’s traded volumes of Homology Medicines Inc?

What is today’s market capitalisation of Homology Medicines Inc?

What is the 52 Week High and Low Range of Homology Medicines Inc?

How much percentage Homology Medicines Inc is down from its 52 Week High?

How much percentage Homology Medicines Inc is up from its 52 Week low?

What are the historical returns of Homology Medicines Inc?

Who is the Chief Executive Officer (CEO) of Homology Medicines Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*